Deferiprone is an orally active bidentate iron chelator that binds ferric iron in a 3:1 molar ratio, used for transfusional iron overload when deferoxamine is inadequate or contraindicated. Simson Pharma's Deferiprone reference standard and impurities support compendial QC for this oral iron chelator.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Deferiprone Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.